Page last updated: 2024-12-07

chaetoglobosins

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chaetoglobosins: like CYTOCHALASINS but with an indoyl in place of a phenyl ring at C10; chaetoglobosins A-J; metabolites of Chaetomium species; RN given refers to chaetoglobosin A; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chaetoglobosin A : A cytochalasan alkaloid isolated from Chaetomium globosum and Calonectria morganii. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID122811
MeSH IDM0071638

Synonyms (8)

Synonym
50335-03-0
chaetoglobosins
chaetoglobosin a
smr000440607
MLS000876953 ,
HMS2269J23
bdbm42463
cid_122811

Research Excerpts

Overview

Chaetoglobosins are a family of macrocyclic polyketide alkaloids.

ExcerptReferenceRelevance
"Chaetoglobosins are a family of macrocyclic polyketide alkaloids. "( Electrospray ionization tandem mass spectrometry of chaetoglobosins.
Fang, DM; Li, GY; Li, LM; Wu, ZJ; Xu, GB; Zhang, GL, 2012
)
2.07

Compound-Compound Interactions

ExcerptReferenceRelevance
"Like the F-actin cross-linking drug MKT-077, the F-actin capping drug CK may be useful for the treatment of Ras-associated cancers if it is combined with the ICE inhibitor N1445, which abolishes the side effect of CK."( Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.
Chen, LB; Cutler, H; Lo, SH; Maruta, H; Tikoo, A,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (8.22)18.7374
1990's4 (5.48)18.2507
2000's12 (16.44)29.6817
2010's36 (49.32)24.3611
2020's15 (20.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.34 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index45.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.19%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (94.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]